ScreenerHero

NUTEXNUTEX Investments Public Limited Company

BUD · HU · Healthcare · Drug Manufacturers - Specialty & Generic · nutex.hu
13.30HUF+9.92%Mkt Cap: 6.44M $P/E: 3.91

NUTEX Investments Public Limited Company provides health preserving, health promotion, nutritional supplement, and cosmetic products in Hungary and internationally. It also engages in asset management. The company was fo…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
MERCK Kommanditgesellschaft auf Aktien
$65.19BUSDP/E 23.7
TAK
Takeda Pharmaceutical Co. Ltd.
$58.06BUSD
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$43.98BUSDP/E 20.4
TEVA
Teva Pharmaceutical Industries Limited
$43.51BUSDP/E 62.2
ZOE
Zoetis Inc.
$29.89BUSDP/E 12.7
ZTS
Zoetis Inc.
$32.12BUSDP/E 12.7
UTHR
United Therapeutics Corporation
$22.01BUSDP/E 18.4
VTRS
Viatris, Inc.
$18.75BUSD
SOBI
Swedish Orphan Biovitrum AB
$15.34BUSDP/E 117.3
IPN
Ipsen S.A.
$14.67BUSDP/E 26.4
NBIX
Neurocrine Biosciences, Inc.
$15.51BUSDP/E 22.3
ELAN
Elanco Animal Health Incorporat
$11.98BUSD
RDY
Dr. Reddy's Laboratories Ltd
$10.15BUSDP/E 29.7
KRK
Krka, d. d.
$8.66BUSDP/E 19.0
ALKS
Alkermes plc
$8.11BUSDP/E 127.2
HIMS
Hims & Hers Health, Inc.
$7.88BUSD
LNTH
Lantheus Holdings Inc
$6.53BUSDP/E 23.9
AMRX
Amneal Pharmaceuticals, Inc. Class A
$6.24BUSDP/E 37.3
LQDA
Liquidia Corporation
$6.14BUSDP/E 49.0
KNSA
Kiniksa Pharmaceuticals, Ltd.
$6.08BUSDP/E 79.8

Key Statistics

Company
Market Cap6.44M $
Enterprise Value-9.22M $
Revenue (TTM)1.27K $
Gross Profit1.27K $
Net Income (TTM)1.40M $
Revenue/Share0.0000 USD
Last Price13.30 HUF
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryHU
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)3.91
P/E (Forward)—
PEG—
EV/EBITDA29.22
EV/Revenue-7252.79
P/S5060.23
P/B0.38
EPS (TTM)3.40
EPS (Forward)—
52W Range
12.0022% of range17.85
52W High17.85 HUF
52W Low12.00 HUF
Profitability
Gross Margin100.00%
Oper. Margin7322.67%
EBITDA Margin0.00%
Profit Margin109815.78%
ROE8.96%
ROA8.90%
Growth
Revenue Growth0.00%
Earnings Growth124.20%
Cash Flow & Leverage
Operating CF724.41K $
CapEx (TTM)1.15K $
FCF Margin-35204.55%
FCF Yield-6.96%
Net Debt-15.19M $
Net Debt/EBITDA48.11
Balance Sheet
Debt/Equity—
Current Ratio155.53
Quick Ratio155.53
Book Value/Sh34.82 HUF
Cash/Share33.92 HUF
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 HUF
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateJun 6, 2011
Pay Date—
Splits
Last Split1:100
Split DateMar 7, 2011
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.171.21M
Float120.91M
Insiders21.93%
Institutions0.00%
Technical
SMA 5013.27 (+0.2%)
SMA 20014.41 (-7.7%)
Beta0.98
S&P 52W Chg18.16%
Avg Vol (30d)68.16K
Avg Vol (10d)122.86K
Technical Indicators
RSI (14)53.3
MACD-0.1290
MACD Signal-0.1328
MACD Hist.+0.0037
BB Upper13.59 HUF
BB Middle12.97 HUF
BB Lower12.35 HUF
BB Width9.52%
ATR (14)0.6500 HUF
Vol Ratio (20d)3.82x